What Implications Do These Sensitivities Have for Treatment?
The heightened sensitivity to DNA-damaging agents in FA patients necessitates careful consideration of treatment regimens. Conventional chemotherapy may need to be adjusted to avoid excessive toxicity. New strategies, such as gene therapy or CRISPR-Cas9 mediated gene editing, are being explored to correct the underlying genetic defects in FA, potentially reducing cancer risks and improving treatment outcomes.
